Calithera Biosciences, Inc. (CALA)

Calithera Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Net Income	-18.87	-165.34	-88.52	-86.35	-51.47	-27.83	-38	-32.64	-21.71	-12.38	Upgrade
Depreciation & Amortization	0.26	0.28	0.36	0.48	0.51	0.37	0.3	0.4	0.36	0.28	Upgrade
Share-Based Compensation	4.03	10.26	8.06	6.47	7.44	5.54	4.25	3.27	0.69	0.07	Upgrade
Other Operating Activities	-29.03	88.49	-4.21	0.66	-21.31	35.68	2.43	-0.97	1.43	0.19	Upgrade
Operating Cash Flow	-43.61	-66.3	-84.31	-78.75	-64.84	13.75	-31.03	-29.93	-19.23	-11.84	Upgrade
Capital Expenditures	-0.13	-0.15	-0.06	-0.01	-0.21	-1.23	-0.4	-0.44	-0.56	-0.16	Upgrade
Acquisitions	0	0	0	0	0	0	-23.71	0	0	0	Upgrade
Change in Investments	-	-8	-203.14	-295.68	-205.23	-292.1	-113.34	-151.86	-	-	Upgrade
Other Investing Activities	-	16	292.16	284.9	258.24	194.5	161.15	85.53	0.07	-0.01	Upgrade
Investing Cash Flow	-0.13	7.85	88.96	-10.78	52.8	-98.83	23.71	-66.78	-0.49	-0.17	Upgrade
Common Stock Issued	9.64	10.66	40.86	97.69	13.71	121.62	11.28	0	71.63	0.07	Upgrade
Share Repurchases	0	0	0	0	0	7.91	0	0	0	0	Upgrade
Other Financing Activities	0.02	0	1.2	1.22	0.92	9.25	0.54	0.85	16.24	43.56	Upgrade
Financing Cash Flow	9.66	10.67	42.06	98.91	14.63	122.95	11.82	0.85	87.87	43.63	Upgrade
Net Cash Flow	-34.09	-47.78	46.71	9.38	2.58	37.87	4.5	-95.86	68.15	31.62	Upgrade
Free Cash Flow	-43.74	-66.45	-84.37	-78.75	-65.06	12.52	-31.43	-30.37	-19.79	-12	Upgrade
Free Cash Flow Margin	-	-681.51%	-	-	-292.33%	48.25%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-8.76	-17.99	-24.52	-33.29	-35.55	7.60	-32.25	-33.66	-85.07	-30.41	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.